| 摘要 |
<p>The invention discloses the use of a lH-indol-3-yl-compound with the formula (I) and any of its stereoisomeric forms or a mixture thereof wherein R1, R3, R4 and R5 are H; R2 is H or OH; A is CH2-CH2; B is 6-CH3-pyrimidine; R6 is H; and R7 is CHR8 (CH2) 3NR9R10; wherein R8 is CH3; R9 and R10 are C2H5; or a salt or solvate of a compound of formula (I) for the treatment of malignant diseases.</p> |
